Severely Debilitating News Today

A new FDA guidance released in Dec. 2021 acknowledges the difficulties inherent in manufacturing individualized antisense oligonucleotide (ASO)...

To eliminate ineffectiveness due to genetic differences, clinical trials of individual patients, described as an “N of 1”...

To eliminate ineffectiveness due to genetic differences, clinical trials of individual patients, described as an “N of 1”...

This Week in Washington: Senate HELP Committee Chair Patty Murray and Ranking Member Richard Burr Release Discussion Draft of Bipartisan Pandemic and Public Health Response Bill.

This Week in Washington: President Biden and Speaker Pelosi Open to Moving Pieces of the Build Back Better Act.

This week in Washington: Supreme Court Rules on Biden Administration Vaccine Mandates.

Upcoming Hearings/Markups - January 11 - Senate Health, Education and Labor Committee Hearing: “Addressing New Variants: A Federal Perspective on the...

This week in Washington: President Biden acknowledges that the Build Back Better Act might not pass Congress this year.

/PRNewswire/ -- The growing clinical effectiveness of the treatment of chimeric antigen receptors (CAR) T-cell therapies in various hematological malignancies,...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news. Week in Review Highlight of the Week: This week, CMS released its FY 2022 Hospital Inpatient Prospective Payment System and Long-Term Care Hospital Rates Proposed Rule. Read more about the rule and other news below. I. Regulations...